From Beginning To End, FDA Transparency Weighed On Sharfstein’s Mind

As a lead player in FDA’s Transparency Initiative, outgoing Principal Deputy Commissioner Joshua Sharfstein helmed a task force that, on his penultimate day at the agency, unveiled a slew of measures to increase industry access to pertinent regulatory information.